David Altarac

Insider Reports History

Location
Waltham, MA
Signature
Elizabeth M. Keiley as Attorney-in-Fact for David Altarac
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Altarac:

Company Role Class Num Shares Value Price $ Report Date Ownership
Entasis Therapeutics Holdings Inc. Chief Medical Officer Common Stock 0 $2.20 11 Jul 2022 Direct
Entasis Therapeutics Holdings Inc. Chief Medical Officer Stock Option (right to buy) 0 11 Jul 2022 Direct

Insider Reports Filed by David Altarac

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465922078787-altarac-david-2022-07-07 Entasis Therapeutics Holdings Inc. 07 Jul 2022 4 -$38,658 4 Chief Medical Officer 11 Jul 2022, 16:03
/report/000110465922005409-altarac-david-2022-01-18 Entasis Therapeutics Holdings Inc. 18 Jan 2022 1 $0 4 Chief Medical Officer 19 Jan 2022, 15:00
/report/000110465921133630-altarac-david-2021-11-02 Entasis Therapeutics Holdings Inc. 02 Nov 2021 1 -$10,787 4 Chief Medical Officer 03 Nov 2021, 16:04
/report/000110465921128056-altarac-david-2021-10-19 Entasis Therapeutics Holdings Inc. 19 Oct 2021 2 -$11,991 4 Chief Medical Officer 20 Oct 2021, 16:06
/report/000110465922023770-altarac-david-2021-07-16 Entasis Therapeutics Holdings Inc. 16 Jul 2021 2 $0 4 Chief Medical Officer 15 Feb 2022, 15:01